This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Elizabeth M Horstman: Innovator in FXR Modulating Compounds
Introduction
Elizabeth M Horstman is a notable inventor based in San Mateo, CA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the FXR (NR1H4) nuclear receptor. Her work is crucial for advancing treatments for various diseases and conditions.
Latest Patents
Elizabeth holds 1 patent related to FXR modulating compounds. The patent details compounds that bind to FXR and act as agonists, which can be utilized in the preparation of medicaments aimed at treating diseases through the binding of this nuclear receptor. The synthesis process of these compounds is also outlined in her patent.
Career Highlights
Elizabeth is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. Her role involves extensive research and development in the field of drug discovery, focusing on innovative solutions for complex health issues.
Collaborations
Throughout her career, Elizabeth has collaborated with esteemed colleagues, including Peter A Blomgren and Kevin S Currie. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Elizabeth M Horstman is a pioneering inventor whose work in FXR modulating compounds holds promise for the future of medicinal treatments. Her contributions to the field exemplify the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile